Cancer vaccine adjuvants – recent clinical progress and future perspectives
Volume: 37, Issue: 1, Pages: 1 - 11
Published: Oct 16, 2014
Abstract
Despite recent breakthroughs in the prognosis, prevention and treatment, cancer still remains the leading cause of death and affects millions of people worldwide. With the US FDA approval of various preventive cancer vaccines such as Gardasil (Merck), Cervarix (Glaxosmithkline) and the therapeutic vaccine Sipulencel-T (Provenge), cancer vaccine development is gaining huge ground. Approval of these vaccines has encouraged the concept of cancer...
Paper Details
Title
Cancer vaccine adjuvants – recent clinical progress and future perspectives
Published Date
Oct 16, 2014
Volume
37
Issue
1
Pages
1 - 11
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History